Literature DB >> 7676717

Optimal timing and indications for cholecystectomy in cardiac transplant patients.

D G Begos1, K L Franco, J C Baldwin, F A Lee, J H Revkin, I M Modlin.   

Abstract

Cardiac transplant is performed with increasing frequency as the treatment for end-stage cardiac disease. Although cholelithiasis is more frequent in both pretransplant and posttransplant patients, no standard management approach exists. Because many such patients are cared for outside the transplant center, it is important that general surgeons develop an appropriate strategy to manage this entity. We present our experience with 11 patients from our institution who underwent cholecystectomy before or after cardiac transplantation. In addition, we have reviewed the 76 reported cases of cholecystectomy performed in precardiac or postcardiac transplant patients from centers throughout the world. Any procedure in this patient group requires critical consideration in regard to the timing and type of procedure. Pretransplant patients are well recognized cardiac risks, and posttransplant immunosuppressed patients are at considerable risk for septic complications. Six patients underwent cholecystectomy prior to heart transplant. Five were performed laparoscopically, one as an open procedure. We also report five laparoscopic cholecystectomies in patients after cardiac transplant. One patient in the pretransplant group died 7 days after surgery from an uncontrollable arrhythmia. There were no hemodynamic or septic complications in either group. Current summated experience (87 cases) indicates that the mortality rate for urgent cholecystectomy in the posttransplant group is at least 36%. Because the first presentation of gallstones in this population is often acute cholecystitis, asymptomatic calculi cannot be considered benign. Elective cholecystectomy, laparoscopic or open, is tolerated well both before and after transplant. Given these facts, it seems reasonable to recommend pretransplant screening and posttransplant surveillance for gallstones.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7676717     DOI: 10.1007/bf00294752

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  28 in total

1.  Prevalence and management of cholelithiasis in heart transplant patients.

Authors:  T B Steck; M R Costanzo-Nordin; A Keshavarzian
Journal:  J Heart Lung Transplant       Date:  1991 Nov-Dec       Impact factor: 10.247

2.  Cyclosporine-induced cholestasis: inhibition of bile acid secretion is caused by the parental molecule.

Authors:  B Le Thai; M Dumont; A Michel; S Erlinger; D Houssin
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

3.  The mechanism of cyclosporine-induced cholestasis in the rat.

Authors:  B Stone; V Warty; V Dindzans; D Van Thiel
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

4.  Laparoscopic cholecystectomy in heart transplant recipients.

Authors:  P Lopez; S V Perrone; J Kaplan; V Serafini; L A Viola; J Decoud; R G Favaloro
Journal:  J Heart Lung Transplant       Date:  1993 Jan-Feb       Impact factor: 10.247

5.  The association between cholesterol cholelithiasis and coronary heart disease in Framingham, Massachusetts.

Authors:  E A Bortnichak; D H Freeman; A M Ostfeld; W P Castelli; W B Kannel; M Feinleib; P M McNamara
Journal:  Am J Epidemiol       Date:  1985-01       Impact factor: 4.897

6.  Management of general surgical problems after cardiac transplantation.

Authors:  M T Jones; A H Menkis; W J Kostuk; F N McKenzie
Journal:  Can J Surg       Date:  1988-07       Impact factor: 2.089

7.  Gastrointestinal complications after human transplantation and mechanical heart replacement.

Authors:  H V Villar; D D Neal; M Levinson; J M Fuller; R W Emery; A R Graham; J Copeland; M J Rhenman; J G Copeland
Journal:  Am J Surg       Date:  1989-01       Impact factor: 2.565

8.  Significance of asymptomatic biliary tract disease in heart transplant recipients.

Authors:  R E Girardet; P Rosenbloom; B M DeWeese; Z H Masri; A A Attum; R N Barbie; S F Yared; R A Lusk; A M Lansing
Journal:  J Heart Transplant       Date:  1989 Sep-Oct

9.  General surgical complications in heart and heart-lung transplantation.

Authors:  D L Steed; B Brown; J J Reilly; A B Peitzman; B P Griffith; R L Hardesty; M W Webster
Journal:  Surgery       Date:  1985-10       Impact factor: 3.982

10.  Longitudinal study of gall stone prevalence at necropsy.

Authors:  T Bates; M Harrison; D Lowe; C Lawson; N Padley
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

View more
  4 in total

1.  Prophylactic cholecystectomy in transplant patients: a decision analysis.

Authors:  Lillian S Kao; Christopher Flowers; David R Flum
Journal:  J Gastrointest Surg       Date:  2005 Sep-Oct       Impact factor: 3.452

2.  The incidence, morbidity, and mortality of surgical procedures after orthotopic heart transplantation.

Authors:  D S Bhatia; J C Bowen; S R Money; C H Van Meter; P M McFadden; J B Kot; A K Pridjian; H O Ventura; M R Mehra; F W Smart; J L Ochsner
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

3.  Management of biliary tract stones in heart transplant patients.

Authors:  M Milas; R R Ricketts; J R Amerson; K Kanter
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

Review 4.  Asymptomatic cholelithiasis: is cholecystectomy really needed? A critical reappraisal 15 years after the introduction of laparoscopic cholecystectomy.

Authors:  George H Sakorafas; Dimitrios Milingos; George Peros
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.487

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.